Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2014-12-23 Director's Dealing
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 3 pages 76.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a director, including the number of shares and options held before and after the change, the nature of the change, and dates. This is a clear report of personal share transactions by a company director. There is no indication of financial results, management discussion, or other report types. The document matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length and content confirm it is not a brief announcement or a certification but a detailed notice of director's interest changes.
2014-12-23 English
Licensing Agreement with Genentech / Roche 2 pages 98.7KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from Phylogica Ltd regarding a new Research and Licensing Agreement with Genentech. It details the terms of the agreement, including upfront payments and potential milestone payments. The document is a corporate announcement about a collaboration and licensing deal, not a financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial data. The document length is 3081 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the most appropriate classification is Capital/Financing Update (CAP), as it relates to company financing activities and agreements.
2014-12-21 English
AGM Presentation 21 pages 2.7MB
AGM Information Classification · 100% confidence The document is titled 'Phylogica 2014 AGM Presentation (PYC:ASX)' and contains slides with business updates, technology updates, corporate snapshot, and future plans. It is explicitly described as a presentation aid for the Annual General Meeting (AGM). The content includes forward-looking statements, company highlights, and strategic information typical of an AGM presentation. There are no detailed financial statements or audit information, nor is it a brief announcement or a certification. The document length is about 10,390 characters, consistent with a presentation rather than a short announcement. Therefore, the document fits the category of AGM Information (AGM-R).
2014-11-26 English
Results of Meeting 1 page 29.6KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'ANNUAL GENERAL MEETING RESULTS' and provides detailed voting outcomes for resolutions considered at the AGM of Phylogica Limited. It includes vote counts for each resolution, proxy details, and references to the Corporations Act and listing rules. The content is focused on the official results of shareholder votes at the AGM, not the meeting materials or the full annual report. The document length is short (2135 characters) and it is clearly an announcement of voting results rather than a report or presentation. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2014-11-26 English
European Patent Synthetic Phylomers 2 pages 129.6KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Phylogica Ltd regarding the allowance of a European patent for synthetic Phylomer libraries. It discusses the patent's implications, the technology, and the company's collaborations. There is no financial data, no report or filing of financial results, no management or board changes, no voting results, no legal proceedings, no capital or financing updates, and no regulatory certifications. The document is an announcement of a patent allowance, which is a regulatory announcement related to intellectual property and company developments. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or others that require financial or governance content. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2014-11-24 English
Trading Policy 8 pages 54.9KB
Governance Information Classification · 95% confidence The document is a detailed policy statement regarding securities trading by Key Management Personnel of Phylogica Ltd. It outlines rules, prohibitions, exceptions, and approval requirements related to insider trading and trading windows. The content focuses on governance and compliance related to insider trading and securities transactions by directors and key employees. There is no financial data, earnings information, or report publication. It is not an announcement of voting results, capital changes, or legal proceedings. The document is a governance-related policy document concerning internal rules and procedures for securities trading by management personnel. Therefore, the most appropriate classification is Governance Information (CGR). The document length and detail support this classification with high confidence.
2014-11-13 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.